Moneycontrol
HomeNewsBusinessCompaniesJ&J says launch date of COVID-19 shots in India not decided, still in talks with govt
Trending Topics

J&J says launch date of COVID-19 shots in India not decided, still in talks with govt

COVID-19 vaccines would be on the agenda of the Quad meeting scheduled on September 24 between the heads of the governments of the US, India, Japan and Australia, sources told Moneycontrol

September 23, 2021 / 18:35 IST
Story continues below Advertisement
A single dose of the Johnson & Johnson COVID-19 vaccine generated neutralizing antibodies against a range of SARS-CoV-2 variants of concern

Johnson & Johnson (J&J) is still in talks with the Indian government about launching its single-dose COVID-19 vaccine, a company spokesperson said, denying reports about a mid-October launch.

"We have received emergency use authorisation, and discussion with Indian government are still on," said the spokesperson of J&J on the latest status of the COVID-19 vaccine. 

Story continues below Advertisement

Reuters reported early this week, citing sources, that India expects to get its first J&J COVID-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker. The report also said India may receive as many as 43.5 million doses of the vaccine in October.

J&J spokesperson said the company was not aware of the launch or the volumes quoted in the story.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show